A Kolkata teacher beats Stage IV ovarian cancer with advanced surgery, genetic testing, and targeted therapy—while inspiring ...

High-grade endometrial carcinomas are a group of diverse and often diagnostically challenging tumors, which include high-grade endometrioid carcinoma (FIGO grade 3), uterine serous carcinoma ...

Advanced-stage high-grade serous carcinoma accounts for most ovarian cancer cases. Current issues in the management of patients with newly diagnosed advanced-stage high-grade serous ovarian cancer ...

Low-grade serous ovarian cancer (LGSOC) presents differently than the more common high-grade serous carcinoma. It tends to show up in younger people, grows slowly, and has higher survival rates.

The principle of separate clinical trials for major rare histologic subtypes of ovarian cancer—clear cell carcinoma, mucinous carcinoma, and low-grade serous carcinoma—was subsequently validated in ...

High-grade serous carcinoma cellsStudy defines key driver of aggressive ovarian cancer Michigan Medicine - University of Michigan Journal Proceedings of the National Academy of Sciences Funder NIH ...

A new study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer—and offers a potential pathway for new treatments. High-grade serous carcinoma, the most common ...

The most common subtype is high-grade serous ovarian cancer, and low-grade serous ovarian cancer , also referred to as low-grade serous carcinoma (LGSOC), is one of the rarer subtypes.

Researchers have made a major breakthrough in understanding the origins of one of the deadliest forms of ovarian cancer, ...

The prognosis is particularly poor in ovarian high grade serous carcinoma (HGSC), a subtype of ovarian cancer. Less than 40% of patients with this subtype survive five years after their diagnosis.

In a recent study, researchers used high-throughput drug screening to identify potential therapeutic targets and novel treatments for low-grade serous ovarian cancer (LGSOC), offering hope for ...